Johns, T., Greenall, S., Chen, S., Stewart, R., Alton, G., & Kesari, S. (2018). DDIS-19. CT-179: AN INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOUR ACTIVITY IN BRAIN CANCER. Neuro Oncol.
Παραπομπή Chicago StyleJohns, Terrance, Sameer Greenall, Shengnan Chen, Rodney Stewart, Gordon Alton, και Santosh Kesari. "DDIS-19. CT-179: AN INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOUR ACTIVITY IN BRAIN CANCER." Neuro Oncol 2018.
Παραπομπή MLAJohns, Terrance, et al. "DDIS-19. CT-179: AN INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOUR ACTIVITY IN BRAIN CANCER." Neuro Oncol 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.